Medical Devices Solutions
Genedrive® MT-RNR1
New revolutionary Point of Care Genetic test (GeneDrive) that give result in 26 minutes and used in NICU & PICU to detect a gene mutation (MT-RNR1) in neonates before administering Aminoglycosides Antibiotics (e.g. Gentamicin) in serious infections (e.g. Neonatal Sepsis). If the patient tests positive for this mutation, he/she will develop irreversible Aminoglycosides Induced Hearing Loss (AGHL) even from one dose!! Thus, alternative antibiotic should be used in such case.
This is the only Point of Care test in the world for this purpose, it is CE-IVD certified, and is now used in UK & other European countries and is recommended by several clinical guidelines including NICE.
Together from Sick Care to Healthcare
Home Care Devices
Write one or two paragraphs describing your product or services. To be successful your content needs to be useful to your readers.
Start with the customer – find out what they want and give it to them.